LABORATORY CORP OF AMERICA HOLDINGS
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
LH$370.88-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Earnings
Index
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS
(In Millions, Except Per Share Data)
| Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net earnings | $419.2 | $1,280.6 | $2,379.5 |
| Foreign currency translation adjustments | 183.1 | (336.4) | (104.6) |
| Net benefit plan adjustments | 14.6 | 44.8 | 91.7 |
| Other comprehensive earnings (loss) before tax | 197.7 | (291.6) | (12.9) |
| Provision for income tax related to items of comprehensive earnings | (1.8) | (9.7) | (17.1) |
| Other comprehensive earnings (loss), net of tax | 195.9 | (301.3) | (30.0) |
| Comprehensive earnings | 615.1 | 979.3 | 2,349.5 |
| Less: Net earnings attributable to the noncontrolling interest | (1.2) | (1.5) | (2.2) |
| Comprehensive earnings attributable to Laboratory Corporation of America Holdings | $613.9 | $977.8 | $2,347.3 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.